Browsing Tag
DEA
2 posts
Eli Lilly (NYSE: LLY) to acquire AtaiBeckley in $3.8bn TRD psychedelic deal
Eli Lilly (NYSE: LLY) to acquire AtaiBeckley for $6.75/share cash plus $2.50 CVR, taking the BPL-003 5-MeO-DMT depression asset to Phase 3 read in 2029.
Wynn Las Vegas hit with massive $130m DOJ settlement in shocking money laundering case
Wynn Resorts, the operator of Wynn Las Vegas, has agreed to forfeit $130 million to the U.S. Department…